Tags

Type your tag names separated by a space and hit enter

Total synthesis of (+)-decursivine.
Org Lett. 2011 Oct 07; 13(19):5302-5.OL

Abstract

The first asymmetric synthesis of natural indole alkaloid (+)-decursivine was accomplished. The key step involves the PIFA-mediated intramolecular [3 + 2] cycloaddition of 5-hydroxytryptophan with a substituted cinnamamide in a highly diastereoselective manner.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Sun D
Department of Chemistry, University of Science and Technology of China, Hefei, Anhui 230026, PR China.
Zhao Q
No affiliation info available
Li C
No affiliation info available

MeSH

5-HydroxytryptophanCinnamatesCyclizationIndole AlkaloidsModels, MolecularMolecular StructureOxidation-ReductionStereoisomerism

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21916429

Citation

Sun, Deqian, et al. "Total Synthesis of (+)-decursivine." Organic Letters, vol. 13, no. 19, 2011, pp. 5302-5.
Sun D, Zhao Q, Li C. Total synthesis of (+)-decursivine. Org Lett. 2011;13(19):5302-5.
Sun, D., Zhao, Q., & Li, C. (2011). Total synthesis of (+)-decursivine. Organic Letters, 13(19), 5302-5. https://doi.org/10.1021/ol2021669
Sun D, Zhao Q, Li C. Total Synthesis of (+)-decursivine. Org Lett. 2011 Oct 7;13(19):5302-5. PubMed PMID: 21916429.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Total synthesis of (+)-decursivine. AU - Sun,Deqian, AU - Zhao,Qiwu, AU - Li,Chaozhong, Y1 - 2011/09/14/ PY - 2011/9/16/entrez PY - 2011/9/16/pubmed PY - 2012/1/18/medline SP - 5302 EP - 5 JF - Organic letters JO - Org Lett VL - 13 IS - 19 N2 - The first asymmetric synthesis of natural indole alkaloid (+)-decursivine was accomplished. The key step involves the PIFA-mediated intramolecular [3 + 2] cycloaddition of 5-hydroxytryptophan with a substituted cinnamamide in a highly diastereoselective manner. SN - 1523-7052 UR - https://www.unboundmedicine.com/medline/citation/21916429/Total_synthesis_of__+__decursivine_ L2 - https://doi.org/10.1021/ol2021669 DB - PRIME DP - Unbound Medicine ER -